Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Explore ways to fund a business with no money. Unlock creative financing options and start your entrepreneurial journey now!
21,633 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Micron stock has captured attention with big moves and big questions. This guide breaks down whether now is the ultim...
More than 200 economists, including 16 Nobel laureates, sign a call admitting they lack clarity on AI's economic effe...
AI hardware competition now hinges on storage alongside compute. NVIDIA drives data-center growth, while SanDisk ride...
Microsoft is at a crossroads as investors await the July 29 results. This article dives into why the stock could rebo...
OpenAI’s CFO unveils a four-question framework to assess whether AI spending actually delivers value. The approach fo...
FTX launches a $900 million creditor payout on July 31 to eligible holders, while 45 jurisdictions remain blocked fro...
A surge in AI inference demands is reshaping Google Cloud’s economics, forcing investors to weigh faster growth again...
As shipping cycles turn, Safe Bulkers faces a critical earnings season. This guide deconstructs the Q4 2025 call, hig...
Global markets jump and contracts tighten as trump’s sudden decision hike lifts the tariff rate to 15% worldwide, ove...
Apple’s next AI chapter hinges on Siri. If the so-called this "siri-ous" problem could derail AI progress, investors ...
Tempus AI reported an 83% jump in Q4 revenue to $367 million but failed to hit positive full-year profitability, guid...